Find Academic Supervisors

• Differentiated Thyroid Cancer
• Thyroid Cancer
• Endocrine Cancer
• +5 more

Thera Links is a Professor at the Faculty of Medical Sciences, University of Groningen, specializing in Personalized Cancer Treatment with a focus on thyroid disorders and endocrine cancers. With over 366 research publications, Dr. Links has established herself as a leading expert in differentiated thyroid cancer, hypothyroidism, and related endocrine disorders. Dr. Links' research interests center on thyroid cancer diagnostics and treatment, particularly focusing on differentiated thyroid cancer, hypothyroidism management, and endocrine tumors like pheochromocytoma. Her work explores innovative approaches to cancer treatment including radiotherapy protocols, molecular diagnostics, and metabolic consequences of thyroid disorders. Analysis of her recent publications reveals a strong focus on clinical applications of thyroid cancer research, with emphasis on treatment optimization, metabolic consequences of thyroid disorders, and advanced diagnostic techniques using genomic and transcriptomic approaches. Her work bridges basic science with clinical applications to improve patient outcomes. NVKC abstractprijs (2025) for research on iodine metabolism Dr. Links has supervised 31 PhD students at the University of Groningen and remains actively involved in academic mentoring. Her research has been supported by multiple grants focused on thyroid cancer treatment optimization and metabolic consequences of thyroid disorders. She serves on the editorial board of the European Thyroid Journal and regularly presents at national and international conferences on thyroid diseases. Dr. Links leads research within the Personalized Cancer Treatment group at UMCG, collaborating with multidisciplinary teams to advance understanding and treatment of endocrine cancers through both clinical and translational research approaches.

• Breast Cancer
• Neoplasm
• Positron Emission Tomography
• +5 more

Dr. Carolien Schröder is a faculty member at the Faculty of Medical Sciences, University Medical Center Groningen (UMCG), part of the University of Groningen. She leads research in the Personalized Cancer Treatment (PCT) department with an extensive research portfolio of 175 publications spanning breast cancer research, molecular imaging, and personalized oncology approaches. Her research expertise demonstrates significant contributions across multiple oncological domains: Breast Cancer (100%) Neoplasm (73%) Positron Emission Tomography (48%) Metastatic Breast Cancer (29%) Estrogen Receptor (27%) Molecular Imaging (24%) Dr. Schröder's recent work focuses on integrating advanced imaging techniques with genomic analysis to develop personalized treatment approaches for breast cancer patients. Her research examines tumor heterogeneity, prognostic factors for therapy response, and the relationship between genomic instability and immune responses in breast cancer, with several high-impact publications appearing in 2024-2025. She has received the Patient Impact award in 2020 for research demonstrating direct clinical relevance to cancer patients. Dr. Schröder actively participates in the academic and clinical oncology community through 64 documented activities including professional presentations, supervision of PhD students, and committee work. Her research has generated significant clinical interest, particularly her work on FES-PET scans as potential alternatives to biopsies for determining hormone sensitivity in metastatic breast cancer, which received media coverage in 2022.

Sjoukje OostingView profile

Professor

• Head and Neck Cancer
• Oncology
• Immune Checkpoint Inhibitors
• +3 more

Sjoukje Oosting is a Professor affiliated with the University of Groningen, contributing to oncology and head and neck cancer research. She specializes in clinical trials, immune checkpoint inhibitors, and radiation therapy. Her work addresses treatment outcomes, quality of life, and biomarkers in cancer patients. Her research focuses on head and neck cancers, renal cell carcinoma, and the effects of immunotherapies. Notable contributions include randomized controlled trials and studies on immune-related side effects like polymyalgia rheumatica. She actively participates in international organizations such as ESMO, chairing committees and presenting at conferences. Her activities emphasize improving clinical benefit scales and patient care in oncology. Dr. Oosting has supervised four PhD students and contributed to over 150 research outputs, with a focus on translational and clinical oncology.

Ruben de KleineView profile

Researcher

• Liver Transplantation
• Pediatrics
• Pediatric Liver Disease
• +3 more

Ruben de Kleine is a researcher at the University of Groningen , specializing in pediatric liver diseases and liver transplantation . His work addresses critical challenges in pediatric hepatology, including acute liver failure , biliary atresia , and post-transplant complications such as portal vein obstruction. As of 2025, he has contributed to over 100 peer-reviewed publications, including studies on neurological outcomes post-transplantation and immunological mechanisms in liver failure.

Patrick DeelenView profile

Researcher

• Genetics
• Transcriptomics
• Population Genetics
• +3 more

Patrick Deelen is a researcher at the University of Groningen, specializing in improving the diagnostic yield of genome sequencing for rare diseases through the integration of population genetics and transcriptomics. He holds a PhD in Bioinformatics (2019) from the University of Groningen, a Master's from Vrije Universiteit Amsterdam (2012), and a Bachelor's from Hanze University of Applied Sciences (2010). His research focuses on genetics, transcriptomics, and computational biology, with contributions to pharmacogenetics, genomic diagnostics, and large-scale gene expression analysis. Key projects include developing clinical-grade pharmacogenetic passports and analyzing context-dependent genetic variants in whole blood. His work has been featured in journals like Nature Communications and Nature Genetics, and he collaborates on datasets related to epigenome-wide association studies. Media coverage highlights his research on genetic influences on lockdown adherence during the pandemic.

• Liver Diseases
• Hepatology
• Transplantation Medicine
• +4 more

Prof. Annette Gouw is a Professor at the University of Groningen, affiliated with the Faculty of Medical Sciences and the Groningen Institute for Organ Transplantation (GIOT). Her research focuses on liver diseases, hepatocellular adenoma, transplantation medicine, and oncology. She collaborates internationally on studies involving liver pathology, imaging techniques, and metabolic dysfunction-associated liver diseases. Recent work includes contributions to understanding vascular disorders in liver pathology and the diagnostic role of histopathology in acute liver disease. Her expertise spans clinical and experimental hepatology, with a strong emphasis on translational research. Education and affiliations: Her academic background and specific educational details are not explicitly provided in the text. However, her affiliation with GIOT and the Faculty of Medical Sciences indicates involvement in medical and translational research programs. Research interests include liver transplantation, hepatocellular carcinoma, bile duct disorders, and molecular mechanisms underlying liver pathologies. She has co-authored over 176 research outputs, including peer-reviewed articles, reviews, and editorials, focusing on diagnostic challenges in hepatology and imaging-pathology correlations. Her work contributes to UN Sustainable Development Goals related to good health and well-being (SDG 3), particularly through advancements in liver disease management and transplant medicine.

Nico van StraalenView profile

Visiting Professor

• Soil Ecology
• Evolutionary Biology
• Environmental Toxicology
• +5 more

Prof. dr. Nico van Straalen serves as a Visiting Professor in the Faculty of Science at Vrije Universiteit Amsterdam, specifically within the Ecology & Evolution department. With an extensive publication record totaling 293 research outputs, he maintains an active research program spanning evolutionary biology, soil ecology, and environmental toxicology. His research interests focus on soil invertebrates, particularly springtails (Collembola) such as Folsomia candida, with expertise in gene expression profiling, transcriptomics, and arthropod biology. His work connects evolutionary adaptations with environmental stress responses, contributing to UN Sustainable Development Goals related to environmental protection. Analysis of his recent publications reveals a strong emphasis on environmental risk assessment, molecular mechanisms of adaptation, and the ecological impacts of emerging contaminants like nanoparticles. His research bridges fundamental evolutionary questions with practical environmental applications, particularly in contaminated ecosystem management. Professor van Straalen has supervised 60 PhD theses throughout his career, demonstrating significant mentorship impact in the field. His academic activities include 25 recorded lectures and presentations, with topics ranging from evolutionary models to molecular mechanisms in soil arthropods. He is currently working on two book projects: 'Soil Invertebrates. Kaleidoscope of Adaptations' (CRC Press) and 'Do Humans Still Evolve?' (Amsterdam University Press), reflecting his dual expertise in soil ecology and evolutionary biology.

Hans van LeeuwenView profile

Professor

• Molecular and cellular physiology
• Skeletal disorders
• Bone metabolism
• +4 more

Hans van Leeuwen is a Full Professor in Internal Medicine at Erasmus University Medical Center. His research focuses on molecular mechanisms underlying skeletal disorders, bone metabolism regulation, and therapeutic innovations. He investigates vitamin D pathways, hormonal control of mineral metabolism, and cancer-bone interactions to develop novel therapeutic strategies. His work aligns with UN Sustainable Development Goals related to health and aging. Key research areas include: Molecular basis of bone strength and repair Therapeutic targets for osteoporosis and metastatic bone disease Vitamin D's role in bone-cell communication Hormonal regulation of calcium/phosphate balance Recent studies explore: β-catenin's role in mesenchymal stem cells under mechanical strain Vasorin's impact on mineral homeostasis Phosphate regulation of FGF23 via MAPK/TGF-β signaling He has supervised 20 research projects and collaborates internationally on bone physiology and cancer research. His work emphasizes translational approaches to clinical challenges in bone health.

• Genetics
• Molecular Biology
• Clinical Genetics
• +12 more

Esther Korpershoek is a Researcher in the Department of Clinical Genetics at Erasmus MC, where she contributes to cutting-edge research in hereditary cancer syndromes and molecular diagnostics. Her work focuses on genetic and molecular mechanisms underlying endocrine and rare tumors. Her research interests span Genetics , Molecular Biology , Clinical Genetics , and Tumor Biology , with a particular emphasis on pheochromocytoma, paraganglioma, SDHx-related syndromes, germline mutations, and neuroendocrine tumors. She utilizes advanced techniques such as transcriptome screening and in vitro tumor modeling to improve diagnostic accuracy and understand disease mechanisms. The analysis of her recent publications reveals a strong trend in molecular oncology, particularly in identifying pathogenic variants in genes like NF1 and MEN1, developing long-term tumor cultures, and exploring morphological and genetic overlaps in rare pediatric tumors. Her work bridges clinical diagnostics with fundamental research, contributing significantly to the understanding of hereditary tumor syndromes. Scientific Awards: No awards listed in the provided text. Esther Korpershoek actively collaborates on multidisciplinary research projects involving genetic diagnostics and tumor pathology. She is involved in studies that have implications for clinical testing and personalized medicine, though specific grants are not mentioned. She has not been identified as advising any students in the provided materials. Labs and Research Teams: She is part of the research network in Clinical Genetics at Erasmus MC, contributing to projects involving molecular diagnostics, tumor culture models, and next-generation sequencing applications in hereditary diseases.

• Genetics
• Molecular Biology
• RNA Splicing
• +4 more

Leontine van Unen is a researcher in the Clinical Genetics department at Erasmus MC, Faculty of Medicine. Her work focuses on improving genetic diagnostics through advanced molecular techniques and transcriptome analysis. Her primary research interests include RNA splicing mechanisms, neurofibromatosis type 1, Legius syndrome, tuberous sclerosis complex (TSC), and variant classification methodologies. She has made significant contributions to understanding how RNA analysis can improve diagnostic yield when DNA testing appears normal. Her recent publications demonstrate a strong trend toward developing more sensitive diagnostic approaches for neurodevelopmental disorders and genetic syndromes, with particular emphasis on transcriptome screening and functional assays to validate variant pathogenicity. Her work bridges basic molecular biology with clinical applications in genetic diagnostics. Dr. van Unen has collaborated extensively with researchers across multiple institutions on projects related to genetic disorder diagnostics and variant interpretation. Her research has been cited multiple times, indicating significant impact in the field of clinical genetics.

• Genetics
• Molecular Biology
• Neurodegenerative Diseases
• +7 more

Anneke Kievit is a researcher in the Department of Clinical Genetics at Erasmus MC, actively contributing to the understanding of genetic and neurodegenerative disorders. Her work spans molecular genetics, transcriptomics, and clinical implications of genetic mutations. Her research interests focus on genetics , neurodegenerative diseases , exome sequencing , and molecular mechanisms of inherited disorders . She investigates conditions such as Parkinson’s disease, intellectual and developmental disabilities, congenital disorders of glycosylation, and optic neuropathies, often using advanced genomic and transcriptomic techniques. The recent publications highlight a strong trend in genetic mechanisms of neurodegeneration , patient-centered genetic counseling , and global collaborative frameworks for equitable research. Her work integrates clinical data with molecular insights to improve diagnosis and understanding of disease progression. Genetic basis of Parkinson’s disease Transcriptomic effects of gene variants Patient preferences in predictive genetics Global inclusion in genetic research Anneke Kievit has not been mentioned in relation to advising students or receiving scientific awards in the provided text. There is no indication of grant leadership or specific funding, though her participation in large collaborative projects suggests involvement in funded research initiatives. She is part of an extensive international network, particularly in Parkinson’s disease research, as evidenced by her contributions to multi-center studies and global data-sharing efforts. While no specific lab or team name is mentioned, her work is embedded within large-scale collaborative consortia focused on genetic neurology.

Mohsen GhanbariView profile

Associate Professor

• Molecular Epidemiology
• Genetics
• Multi-Omics
• +12 more

Mohsen Ghanbari is an Associate Professor in the Department of Epidemiology at Erasmus MC, Rotterdam. He leads the 'Molecular & Systems Epidemiology' research line as Principal Investigator, overseeing a multidisciplinary team of MSc students, PhD candidates, postdoctoral researchers, and lab technicians. His work is deeply embedded in large-scale population studies, including the Rotterdam Study and the Erasmus Rucphen Family (ERF) study. Research Interests: Dr. Ghanbari’s research focuses on uncovering genetic determinants and identifying novel biomarkers for complex age-related diseases such as Alzheimer’s disease, cardiometabolic disorders, and fatty liver disease. He integrates multi-omics data—genomics, epigenomics, metabolomics, and transcriptomics—using advanced analytical and molecular techniques. His work aims to elucidate disease mechanisms and improve early diagnosis and risk stratification. Recent Research Trends: His most recent publications (2025) highlight a strong focus on aging, biomarker discovery, and population genomics. Articles span diverse areas including metabolomics of adipose tissue, plasma microRNA signatures in aging, Y-chromosome variation in forensics, environmental-genetic interactions in mortality, and non-coding RNA in eye disorders. These reflect a cohesive trajectory toward systems-level understanding of aging and complex diseases. Scientific Recognition: His work has been published in high-impact journals such as Nature Medicine , Genome Medicine , and Human Genetics . His research has been widely disseminated, with mentions in 325 news outlets, over 1,000 posts on X (formerly Twitter), and engagement across Facebook, Bluesky, and Reddit, indicating significant academic and public impact. Teaching and Supervision: Dr. Ghanbari is actively involved in academic education, coordinating multiple courses through the Netherlands Institute for Health Sciences (NIHES) at Erasmus MC Graduate School. He supervises MSc and PhD students, though specific names are not listed in the provided text. He also manages omics data for the Rotterdam Study and leads the ERF study. Collaborations and Infrastructure: He participates in numerous international multicenter consortia focused on population omics and age-related diseases, reflecting a strong collaborative network. His lab functions as a hub for molecular and systems epidemiology, integrating bioinformatics with experimental validation.

• Pancreatic Cancer
• Immunology
• Oncology
• +7 more

Fleur van der Sijde is a Researcher at Erasmus MC in the Department of General Practice, focusing on clinical and translational oncology, particularly in pancreatic cancer. Her work integrates immunology and molecular diagnostics to improve treatment outcomes. Research Interests: Her research centers on understanding tumor progression, immune response modulation during chemotherapy, and identifying predictive biomarkers in pancreatic ductal adenocarcinoma. She investigates serum cytokine dynamics, gene expression profiles, and immune cell populations to determine early response to FOLFIRINOX therapy. The recent publications show a strong trend in immuno-oncology , emphasizing the interplay between systemic immunity and chemotherapy efficacy. Her work leverages flow cytometry, transcriptomics, and clinical cohort data to uncover mechanisms of treatment resistance and survival predictors. Scientific Contributions: Developed multigene circulating biomarkers for early prediction of chemotherapy response. Demonstrated association between cytokine levels and tumor progression/survival. Highlighted methodological impacts of data analysis techniques on clinical discoveries. Advising and Grants: While no formal advisees or grant details are mentioned, her involvement in multi-center studies and doctoral thesis suggests active participation in collaborative research projects under senior supervision. She likely contributes to study design, data analysis, and manuscript preparation in high-impact oncology research. Labs and Teams: Works within a multidisciplinary oncology research team at Erasmus MC, collaborating with experts in surgery, medical oncology, immunology, and molecular diagnostics. The team focuses on improving outcomes for pancreatic cancer patients through personalized medicine approaches.

• Molecular Genetics
• Bioinformatics
• Computational Biology
• +4 more

Li You serves as a Researcher in the Department of Molecular Genetics at Erasmus Medical Center, Erasmus University Rotterdam. Their work integrates computational methodologies with biomedical research to develop AI-driven solutions for healthcare challenges, particularly in genomic analysis and medical imaging. Research focuses on Molecular Genetics and Bioinformatics, with specialized expertise in RNA sequencing, transcriptomics, and single-cell analysis. Key investigations include tumor cell dynamics, expression-level modeling, and transfer learning applications. The interdisciplinary approach bridges computer science and molecular biology to address complex biological questions through emerging technologies like deep learning and neural networks. Recent publications (2023-2025) reveal a consistent trajectory in applying artificial intelligence to medical diagnostics and biological imaging. Core themes include arrhythmia classification, cardiac segmentation, 3D reconstruction for metaverse applications, and real-time cell analysis. This work demonstrates strong cross-disciplinary integration of computer vision, biomedical engineering, and molecular genetics to advance precision medicine tools.

Harmen van de WerkenView profile

Assistant Professor

• Genomics
• Molecular Biology
• Immunology
• +12 more

Harmen van de Werken is an Assistant Professor at Erasmus MC, a leading academic medical center in the Netherlands. His research is highly interdisciplinary, bridging genomics, immunology, and molecular biology with applications in liver disease, cancer, and immunotherapy. His research interests focus on understanding the molecular and immunological mechanisms underlying chronic viral infections, particularly hepatitis B, and immune cell dysfunction. He utilizes cutting-edge technologies such as organoid models, single-cell transcriptomics, and chromosome conformation capture to dissect gene regulation and cellular responses in disease contexts. The recent trend in his publications reflects a dual focus: (1) immunogenomics of hepatitis B and metabolic liver disease, and (2) immune cell engineering and machine learning applications in clinical prognosis. His work frequently appears in high-impact journals such as Nature Communications and Journal of Hepatology , indicating strong recognition in both basic and translational research domains. While no specific scientific awards are listed in the provided text, his research has garnered citations and attention across academic and social media platforms, including Mendeley, X (formerly Twitter), and Facebook, suggesting growing influence in the scientific community. Harmen van de Werken supervises research work, as indicated by the 'Supervised Work (3)' section, though specific student names are not provided. His collaborative network spans multiple institutions and countries, reflecting an active role in international biomedical research. He is involved in projects integrating wet-lab biology with computational modeling, suggesting leadership in interdisciplinary teams focused on systems-level understanding of disease.